Prescription Medications, Brand Names Beginning with ‘D’

Page 1 of 525 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

D-Care 100X (Lidocaine Hydrochloride, Povidone-Iodine, Isopropyl Alcohol)

Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional…

RX PHARMA-PACK, INC.26 October 2018

D-Penamine (Penicillamine)

Dear Health Care Provider: Due to the shortage of penicillamine titratable tablets in the United States (U.S.) market. Mylan is coordinating with the U.S. Food and Drug Administration…

Mylan Pharmaceuticals Inc.13 November 2018

D.H.E. 45 (Dihydroergotamine Mesylate)

D.H.E. 45 (dihydroergotamine mesylate) Injection USP is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes…

Valeant Pharmaceuticals North America6 November 2017

D.H.E. 45 (Dihydroergotamine Mesylate)

D.H.E. 45 (dihydroergotamine mesylate) Injection USP is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes…

Bausch Health US, LLC6 November 2017

Dacarbazine is indicated in the treatment of metastatic malignant melanoma. In addition, dacarbazine is also indicated for Hodgkin’s disease as a second-line therapy when used in combination with other effective agents. CONTRAINDICATIONS:…

Bedford Laboratories5 May 2010

Page 1 of 525 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Surgical Gowns and Packs by Cardinal Health: FDA Statement – Potential Quality Issues Affecting Some of its Level 3 Surgical Gowns and Accompanying PreSource Procedural Packs
Thu, 16 Jan 2020. The medical device manufacturer Cardinal Health alerted its customers to potential quality issues affecting some of its Level 3 surgical gowns and accompanying PreSource procedural packs.
FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products Within Expiry Due to A Lack of Assurance of Sterility
Wed, 15 Jan 2020. FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry, to the user level, due to a lack of assurance of sterility. The recalled sterile products have been found to be…

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.